GRDN Dividend: Guardian Pharmacy Services Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

GRDN Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,389	1,228	1,046	908	792	735
Revenue Growth (YoY)	56%	17%	15%	15%	8%	5%
Cost of Revenue	1,115	984	837	723	630	588
Gross Profit	274	244	208	185	161	147
Selling, General & Admin	215	297	158	126	123	102
Research & Development	--	--	--	--	--	--
Operating Expenses	215	307	167	133	131	114
Other Non Operating Income (Expenses)	0	0	0	0	0	-1
Pretax Income	58	-66	37	49	28	29
Income Tax Expense	19	4	--	--	--	--
Net Income	40	-110	23	35	16	19
Net Income Growth	-133%	-578%	-34%	119%	-16%	-10%
Shares Outstanding (Diluted)	62.12	62	62.09	62.09	62.09	62.09
Shares Change (YoY)	2%	0%	0%	0%	0%	0%
EPS (Diluted)	0.63	-1.77	0.38	0.57	0.26	0.32
EPS Growth	-132%	-567%	-33%	119%	-19%	-9%
Free Cash Flow	68	41	56	31	49	44
Free Cash Flow Per Share	1.09	0.66	0.9	0.49	0.78	0.7
Gross Margin	19.72%	19.86%	19.88%	20.37%	20.32%	20%
Operating Margin	4.17%	-5.04%	3.82%	5.61%	3.78%	4.35%
Profit Margin	2.87%	-8.95%	2.19%	3.85%	2.02%	2.58%
Free Cash Flow Margin	4.89%	3.33%	5.35%	3.41%	6.18%	5.98%
EBITDA	79	-43	58	67	46	49
EBITDA Margin	5.68%	-3.5%	5.54%	7.37%	5.8%	6.66%
D&A For EBITDA	21	19	18	16	16	17
EBIT	58	-62	40	51	30	32
EBIT Margin	4.17%	-5.04%	3.82%	5.61%	3.78%	4.35%
Effective Tax Rate	32.75%	-6.06%	--	--	--	--